Abstract:Background and Aim Nonalcoholic fatty liver disease (NAFLD) is currently one of the most common chronic liver diseases worldwide, characterized by the presence of lipid droplets. Rab18 is an important lipid droplet protein; however, its effects and mechanisms of action on NAFLD remain unclear. Methods Free fatty acid‐stimulated AML‐12 cells and high‐fat diet (HFD)‐fed mice were used as NAFLD models. Lentiviruses overexpressing Rab18 (Rab18‐OE) or knockdown (Rab18‐KD) were used to generate stable cell lines for genetic analysis. Blood serum levels of alanine aminotransferase, aspartate aminotransferase, total cholesterol, triglycerides, high‐density lipoprotein cholesterol, low‐density lipoprotein cholesterol, glucose, and leptin were measured using a biochemical autoanalyzer. Hematoxylin and eosin staining was performed to detect pathological damage to the liver. Lipid accumulation in the cells was assessed by Oil Red O staining. Target expression was measured using qPCR, western blotting, and immunocytochemistry. Results Rab18 mRNA and protein expression levels increased in free fatty acid‐stimulated AML‐12 cells and the livers of HFD‐fed mice. Rab18‐OE increased lipid accumulation in vitro, which was attenuated by Rab18‐KD. In vivo, Rab18‐OE augmented liver pathological damage, serum alanine aminotransferase/aspartate aminotransferase activity, and triglyceride, total cholesterol, and low‐density lipoprotein levels, whereas Rab18‐KD decreased these indicators. Rab18‐KD also downregulated blood glucose levels in HFD‐fed mice. Mechanistically, Rab18‐OE and Rab18‐KD regulated the mRNA and protein expression levels of perilipin 2 (PLIN2) and peroxisome proliferator‐activated receptor gamma (PPARγ) in vitro and in vivo, respectively. Immunocytochemistry revealed that Rab18 colocalized with PLIN2 and PPARγ in AML‐12 cells. Conclusion Rab18 expression was elevated in vitro and in vivo in the NAFLD mouse model. Rab18 regulates PLIN2 and PPARγ expression to exaggerate liver injury and lipid accumulation in patients with NAFLD. Thus, Rab18 may be a crucial protein in this disease and a potential therapeutic target.

Rab18 promotes lipid droplet (LD) growth by tethering the ER to LDs through SNARE and NRZ interactions

Characterization of the Role of Rab18 in Mediating LD–ER Contact and LD Growth

Rab1b facilitates lipid droplet growth by ER–to–lipid droplet targeting of DGAT2

Rab2A-mediated Golgi-lipid Droplet Interactions Support Very-Low-density Lipoprotein Secretion in Hepatocytes

The ER-Localized Protein DFCP1 Modulates ER-Lipid Droplet Contact Formation.

Rab8a-AS160-MSS4 Regulatory Circuit Controls Lipid Droplet Fusion and Growth.

A RasGAP, DAB2IP, Regulates Lipid Droplet Homeostasis by Serving As GAP Toward RAB40C.

RNF115 Inhibits the Post‐ER Trafficking of TLRs and TLRs‐Mediated Immune Responses by Catalyzing K11‐Linked Ubiquitination of RAB1A and RAB13

Small GTPase Rab40c Associates with Lipid Droplets and Modulates the Biogenesis of Lipid Droplets

Rab32 is important for autophagy and lipid storage in Drosophila.

Qa-SNARE syntaxin 18 mediates lipid droplet fusion with SNAP23 and SEC22B

Regulation of lipid homeostasis by the TBC protein dTBC1D22 via modulation of the small GTPase Rab40 to facilitate lipophagy

Analysis of Biogenesis of Lipid Droplets by Examining Rab40c Associating with Lipid Droplets.

Mmbcfa C17iso Ensures Endoplasmic Reticulum Integrity for Lipid Droplet Growth

The small GTPase RAB-18 is involved in regulating development/diapause by recruiting the intestinal cholesterol transporter NCR-1 onto the apical side in Caenorhabditis elegans

COPI–TRAPPII Activates Rab18 and Regulates Its Lipid Droplet Association

Effect of Rab18 on liver injury and lipid accumulation by regulating perilipin 2 and peroxisome proliferator‐activated receptor gamma in non‐alcoholic fatty liver disease

RalA and PLD1 promote lipid droplet growth in response to nutrient withdrawal

An Arabidopsis Rab18 GTPase promotes autophagy by tethering ATG18a to the ER in response to nutrient starvation

Rab18 maintains homeostasis of subcutaneous adipose tissue to prevent obesity-induced metabolic disorders

LET-767 Determines Lipid Droplet Protein Targeting and Lipid Homeostasis.